Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka

  • Shanika Nanayakkara
  • Toshiyuki Komiya
  • Neelakanthi Ratnatunga
  • S. T. M. L. D. Senevirathna
  • Kouji H. Harada
  • Toshiaki Hitomi
  • Glenda Gobe
  • Eri Muso
  • Tilak Abeysekera
  • Akio Koizumi
Regular Article

Abstract

Chronic kidney disease of uncertain etiology (CKDu) in North Central Province of Sri Lanka has become a key public health concern in the agricultural sector due to the dramatic rise in its prevalence and mortality among young farmers. Although cadmium has been suspected as a causative pathogen, there have been controversies. To date, the pathological characteristics of the disease have not been reported. Histopathological observations of 64 renal biopsies obtained at Anuradhapura General Hospital from October 2008 to July 2009 were scored according to Banff 97 Working Classification of Renal Allograft pathology. The correlations between the histological observations and clinical parameters were statistically analyzed. Interstitial fibrosis and tubular atrophy with or without nonspecific interstitial mononuclear cell infiltration was the dominant histopathological observation. Glomerular sclerosis, glomerular collapse, and features of vascular pathology such as fibrous intimal thickening and arteriolar hyalinosis were also common. Although hypertension was identified as one of the common clinical features among the cases, it did not influence the histopathological lesions in all the cases. This study concludes that tubulointerstitial damage is the major pathological lesion in CKDu. Exposure(s) to an environmental pathogen(s) should be systematically investigated to elucidate such tubulointerstitial damage in CKDu.

Keywords

Chronic kidney disease Farmers Cadmium Histopathology Sri Lanka 

Supplementary material

12199_2011_243_MOESM1_ESM.doc (42 kb)
Supplementary material 1 (DOC 42.5 kb)

References

  1. 1.
    Manns B, Hemmelgarn B, Tonelli M, Au F, Chiasson TC, Dong J, Klarenbach S. Population based screening for chronic kidney disease: cost effectiveness study. BMJ. 2010;341:c5869.PubMedCrossRefGoogle Scholar
  2. 2.
    Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS. Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis. 2010;17:254–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Chandrajith R, Nanayakkara S, Itai K, Aturaliya TN, Dissanayake CB, Abeysekera T, Harada K, Watanabe T, Koizumi A. Chronic kidney diseases of uncertain etiology (CKDue) in Sri Lanka: geographic distribution and environmental implications. Environ Geochem Health. 2011;33:267–78.PubMedCrossRefGoogle Scholar
  4. 4.
    Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R, Hittarage A. Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease. Trans R Soc Trop Med Hyg. 2007;101:1013–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Kawano S, Nakagawa H, Okumura Y, Tsujikawa K. A mortality study of patients with Itai–itai disease. Environ Res. 1986;40:98–102.PubMedCrossRefGoogle Scholar
  6. 6.
    Bandara JM, Senevirathna DM, Dasanayake DM, Herath V, Abeysekara T, Rajapaksha KH. Chronic renal failure among farm families in cascade irrigation systems in Sri Lanka associated with elevated dietary cadmium levels in rice and freshwater fish (Tilapia). Environ Geochem Health. 2008;30:465–78.PubMedCrossRefGoogle Scholar
  7. 7.
    Bandara JM, Wijewardena HV, Liyanege J, Upul MA. Chronic renal failure in Sri Lanka caused by elevated dietary cadmium: Trojan horse of the green revolution. Toxicol Lett. 2010;198:33–9.CrossRefGoogle Scholar
  8. 8.
    Khajehdehi P, Junaid SM, Salinas-Madrigal L, Schmitz PG, Bastani B. Percutaneous renal biopsy in the 1990s: safety, value, and implications for early hospital discharge. Am J Kidney Dis. 1999;34:92–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Howie A. Renal Biopsy. Medicine Renal 1. 2003;31:29–31.Google Scholar
  10. 10.
    Foundation NK KDOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, classification, and stratification. http://www.kidney.org/professionals/KDOQI/guidelines_ckd/toc.htm. Accessed 26 Dec 2010.
  11. 11.
    Kooman JP. Estimation of renal function in patients with chronic kidney disease. J Magn Reson Imaging. 2009;30:1341–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Rivera F, Lopez-Gomez JM, Perez-Garcia R. Clinicopathologic correlations of renal pathology in Spain. Kidney Int. 2004;66:898–904.PubMedCrossRefGoogle Scholar
  14. 14.
    Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS, Sinclair R, McNeil JJ, Atkins RC. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant. 2001;16:1364–7.CrossRefGoogle Scholar
  15. 15.
    Hughson MD, Johnson K, Young RJ, Hoy WE, Bertram JF. Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. Am J Kidney Dis. 2002;39:679–88.PubMedCrossRefGoogle Scholar
  16. 16.
    Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 2006;70:104–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Sterzel RB, Schulze-Lohoff E, Marx M. Cytokines and mesangial cells. Kidney Int Suppl. 1993;39:S26–31.PubMedGoogle Scholar
  18. 18.
    Speirs RS. Cells involved in hypersensitivity and immunity. Blood. 1963;22:363–7.PubMedGoogle Scholar
  19. 19.
    Neusser MA, Lindenmeyer MT, Moll AG, Segerer S, Edenhofer I, Sen K, Stiehl DP, Kretzler M, Grone HJ, Schlondorff D, Cohen CD. Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol. 2010;176:594–607.PubMedCrossRefGoogle Scholar
  20. 20.
    Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008;17:266–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Caetano ER, Zatz R, Saldanha LB, Praxedes JN. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension. 2001;38:171–6.PubMedGoogle Scholar
  22. 22.
    Nanayakkara S, Senevirathna STMLD, Karunaratne U, Chandrajith R, Harada KH, Hitomi T, Watanabe T, Abeysekera T, Aturaliya TNC, Koizumi A, Consortium CKDoUA (2011) Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross sectional study. Environ Health Prev Med (in press).Google Scholar
  23. 23.
    Kido T, Nordberg GF, Roels HA. Cadmium-induced renal effects. In: Clinical nephrotoxins: renal injury from drugs and chemicals. 3rd ed, chap 35. New York: Springer Science+Business Media, pp 785–811.Google Scholar
  24. 24.
    Nogawa K, Yamada Y, Honda R, Ishizaki M, Tsuritani I, Kawano S, Kato T. The relationship between itai–itai disease among inhabitants of the Jinzu River basin and cadmium in rice. Toxicol Lett. 1983;17:263–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Bonnell JA, Ross JH, King E. Renal lesions in experimental cadmium poisoning. Br J Ind Med. 1960;17:69–80.PubMedGoogle Scholar
  26. 26.
    Bamias G, Boletis J. Balkan nephropathy: evolution of our knowledge. Am J Kidney Dis. 2008;52:606–16.PubMedCrossRefGoogle Scholar
  27. 27.
    Schiller A, Gusbeth-Tatomir P, Pavlovic N, Ferluga D, Spasovski G, Covic A. Balkan endemic nephropathy: a still unsolved puzzle. J Nephrol. 2008;21:673–80.PubMedGoogle Scholar
  28. 28.
    Shaohua Z, Ananda S, Ruxia Y, Liang R, Xiaorui C, Liang L. Fatal renal failure due to the Chinese herb “GuanMu Tong” (Aristolochia manshuriensis): autopsy findings and review of literature. Forensic Sci Int. 2010;199:e5–7.PubMedCrossRefGoogle Scholar
  29. 29.
    de Jonge H, Vanrenterghem Y. Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy. Nephrol Dial Transplant. 2008;23:39–41.PubMedCrossRefGoogle Scholar
  30. 30.
    Fuchs R, Peraica M. Ochratoxin A in human kidney diseases. Food Addit Contam. 2005;22:53–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Krogh P, Elling F, Gyrd-Hansen N, Hald B, Larsen AE, Lillehoj EB, Madsen A, Mortensen HP, Ravnskov U. Experimental porcine nephropathy: changes of renal function and structure perorally induced by crystalline ochratoxin A. Acta Pathol Microbiol Scand A. 1976;84:429–34.PubMedGoogle Scholar
  32. 32.
    Desalegn B, Nanayakkara S, Harada KH, Hitomi T, Chandrajith R, Karunaratne U, Abeysekera T, Koizumi A, Consortium CKDoUE. Mycotoxin detection in urine samples from patients with chronic kidney disease of uncertain etiology in Sri Lanka. Bull Environ Contam Toxicol. 2011;87:6–10.PubMedCrossRefGoogle Scholar
  33. 33.
    Yang CC, Wu ML, Deng JF. Prolonged hemolysis and methemoglobinemia following organic copper fungicide ingestion. Vet Hum Toxicol. 2004;46:321–3.PubMedGoogle Scholar
  34. 34.
    Schuurman M, van Waardenburg D, Da Costa J, Niemarkt H, Leroy P. Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency: case report and literature review. Eur J Pediatr. 2009;168:779–82.PubMedCrossRefGoogle Scholar
  35. 35.
    Srinivas R, Agarwal R, Jairam A, Sakhuja V. Intravascular haemolysis due to glucose-6-phosphate dehydrogenase deficiency in a patient with aluminium phosphide poisoning. Emerg Med J. 2007;24:67–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Xiong X, Liu J, He W, Xia T, He P, Chen X, Yang K, Wang A. Dose-effect relationship between drinking water fluoride levels and damage to liver and kidney functions in children. Environ Res. 2007;103:112–6.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society for Hygiene 2011

Authors and Affiliations

  • Shanika Nanayakkara
    • 1
  • Toshiyuki Komiya
    • 2
  • Neelakanthi Ratnatunga
    • 3
  • S. T. M. L. D. Senevirathna
    • 1
  • Kouji H. Harada
    • 1
  • Toshiaki Hitomi
    • 1
  • Glenda Gobe
    • 4
  • Eri Muso
    • 2
  • Tilak Abeysekera
    • 5
  • Akio Koizumi
    • 1
  1. 1.Department of Health and Environmental SciencesKyoto University Graduate School of MedicineKyotoJapan
  2. 2.Department of Nephrology and DialysisTazuke Kofukai Medical Research Institute Kitano HospitalOsakaJapan
  3. 3.Department of Pathology, Faculty of MedicineUniversity of PeradeniyaPeradeniyaSri Lanka
  4. 4.Department of Molecular and Cellular Pathology, School of Medicine, Princess Alexandra HospitalUniversity of QueenslandBrisbaneAustralia
  5. 5.Nephrology UnitGeneral Hospital (Teaching)KandySri Lanka

Personalised recommendations